Global Health Receives 'Sell' Rating from MarketsMOJO Due to Technical Analysis and High Valuation

Nov 27 2024 07:09 PM IST
share
Share Via
Global Health, a largecap company in the hospital and healthcare services industry, has received a 'Sell' rating from MarketsMojo due to technical analysis and high valuation. However, the company has shown strong long-term growth and positive results, with a low Debt to Equity ratio and high institutional holdings. Investors should carefully consider these factors before making any investment decisions.
Global Health, a largecap company in the hospital and healthcare services industry, has recently received a 'Sell' rating from MarketsMOJO on 27 November 2024. This downgrade is based on technical analysis, as the stock is currently in a Mildly Bearish range and the Bollinger Band has been Bearish since 25 November 2024.

In terms of valuation, the stock has a high ROE of 15.5 and a Price to Book Value of 9.2, making it very expensive. However, it is currently trading at a fair value compared to its historical valuations. Over the past year, the stock has generated a return of 19.13%, while its profits have increased by 19.4%. The PEG ratio of the company is 3.1, indicating a slightly overvalued stock.

On the positive side, Global Health has a low Debt to Equity ratio of 0 times, indicating a healthy financial position. The company has also shown strong long-term growth, with an annual growth rate of 20.10% in Net Sales and 160.32% in Operating profit.

In the latest quarter, the company has reported positive results, with the highest OPERATING PROFIT TO INTEREST(Q) at 14.29 times, NET SALES(Q) at Rs 956.56 cr, and PBDIT(Q) at Rs 228.29 cr.

Another factor to consider is the high institutional holdings of 23.31%. These investors have the resources and capability to thoroughly analyze the fundamentals of companies, making their investment decisions more reliable.

In conclusion, while Global Health has shown strong growth and positive results, the current technical trend and high valuation make it a 'Sell' according to MarketsMOJO. Investors should carefully consider these factors before making any investment decisions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read